Pidotimod
|
|
|
- CAS-Nr.
- 121808-62-6
- Englisch Name:
- Pidotimod
- Synonyma:
- Adimod;3-L-pyroglutaMyl-L-thiazolidine-4-carboxylic acid;Axil;Onaka;pgt/1a;PoliMod;Pidomod;PIDOTIMOD;Pidomomod;Pidolimod
- CBNumber:
- CB9745917
- Summenformel:
- C9H12N2O4S
- Molgewicht:
- 244.27
- MOL-Datei:
- 121808-62-6.mol
|
Pidotimod Eigenschaften
- Schmelzpunkt:
- 194-198°C (dec.)
- alpha
- D25 -150° (c = 2 in 5N HCl)
- Siedepunkt:
- 663.0±55.0 °C(Predicted)
- Dichte
- 1.53
- storage temp.
- Keep in dark place,Sealed in dry,2-8°C
- Löslichkeit
- DMSO (Slightly, Heated), Methanol (Slightly, Heated), 5N HCl (Slightly)
- Aggregatzustand
- powder
- pka
- 3.03(at 25℃)
- Farbe
- white to beige
- Optische Aktivität
- [α]/D -135 to -155°, c = 1 in 6 M HCl
- Merck
- 14,7419
- InChI
- InChI=1S/C9H12N2O4S/c12-7-2-1-5(10-7)8(13)11-4-16-3-6(11)9(14)15/h5-6H,1-4H2,(H,10,12)(H,14,15)/t5-,6-/m0/s1
- InChIKey
- UUTKICFRNVKFRG-WDSKDSINSA-N
- SMILES
- S1C[C@@H](C(O)=O)N(C([C@@H]2CCC(=O)N2)=O)C1
- CAS Datenbank
- 121808-62-6(CAS DataBase Reference)
Sicherheit
- Risiko- und Sicherheitserklärung
- Gefahreninformationscode (GHS)
| RTECS-Nr. |
XJ5426675 |
|
|
| HS Code |
2934.10.9000 |
|
|
| Toxizität |
LD50 in mice and rats (mg/kg): >4000 i.v.; >4000 i.m.; >8000 i.p.; >8000 orally (Coppi) |
|
|
| Bildanzeige (GHS) |
|
| Alarmwort |
Warnung |
| Gefahrenhinweise |
| Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
| H302 |
Gesundheitsschädlich bei Verschlucken. |
Akute Toxizität oral |
Kategorie 4 |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
P264, P270, P301+P312, P330, P501 |
| H315 |
Verursacht Hautreizungen. |
Hautreizung |
Kategorie 2 |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
P264, P280, P302+P352, P321,P332+P313, P362 |
| H319 |
Verursacht schwere Augenreizung. |
Schwere Augenreizung |
Kategorie 2 |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
P264, P280, P305+P351+P338,P337+P313P |
| H335 |
Kann die Atemwege reizen. |
Spezifische Zielorgan-Toxizität (einmalige Exposition) |
Kategorie 3 (Atemwegsreizung) |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
|
|
| Sicherheit |
| P261 |
Einatmen von Staub vermeiden. |
| P305+P351+P338 |
BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach Möglichkeit entfernen. Weiter spülen. |
|
Pidotimod Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
Pidotimod, a dipeptide immunomodulating agent, has been introduced as
immunostimulant therapy in patients with cell-mediated immunosuppression during respiratory
or urinary tract infections. Its mode of action on the immune system is by activation of
T-lymphocytes via interleukin (IL)-2 stimulation and macrophages via activation of superoxide
dismutase and chemotaxis. In mice, treatment with pidotimod causes significant increase in
the natural killer cell activity that may play an important role in immunosurveillance against
tumors and in physiological homeostasis. Pidotimod can reverse the immunosuppression
caused by surgical stress and has antiinflammatory, antioxidant, and antiaging properties. It
has also been reported to provide protection from bacterial infections in mice.
Chemische Eigenschaften
White Solid
Verwenden
Immunostimulant used in patients with cell-mediated immunodepression.
Pidotimod Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Pidotimod Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 439)Lieferanten
121808-62-6()Verwandte Suche:
- (4R)-3-[(2S)-5-Oxopyrrolidine-2-carbonyl]-1,3-thiazolidine-4-carboxylic acid
- (4S)-3-(5-Oxo-L-prolyl)thiazolidine-4-carboxylic acid
- 3-Pyroglutamoylthiazolidine-4-carboxylic acid
- (4R)-3-[(2S)-5-ketopyrrolidine-2-carbonyl]thiazolidine-4-carboxylic acid
- (4R)-3-[(2S)-5-oxopyrrolidin-2-yl]carbonyl-1,3-thiazolidine-4-carboxylic acid
- (R)-3-((S)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid
- Axil
- Onaka
- PoliMod
- 4-Thiazolidinecarboxylic acid, 3-[[(2S)-5-oxo-2-pyrrolidinyl]carbonyl]-, (4R)-
- PidotiMod API
- 3-(5-OXO-2-PYRROLIDINYL)CARBONYL-4-THIAZOLIDINECARBOXYLICACID
- (R)-3-((S)-2-oxopyrrolidine-5-carbonyl)thiazolidine-4-carboxylic acid
- ((R)-3-[(S)-(5-oxo-2-pyrrolidinyl) carbonyl]-thiazolidine-4-carboxylic acid
- (r-(r*,s*))-3-((5-oxo-2-pyrrolidinyl)carbonyl)-4-thiazolidinecarboxylicacid
- (r)-3-((s)-(5-oxo-2-pyrrolidinyl)carbonyl)-thiazolidin-4-carbonsaeure
- 4-thiazolidinecarboxylicacid,3-((5-oxo-2-pyrrolidinyl)carbonyl)-,(r-(r*,s*))
- pgt/1a
- (R)-3-[(S)-(5-OXO-2-PYRROLIDINYL)CARBOXYL]-THIAZOLIDINE-4-CARBOCYLIC ACID
- PIDOTIMOD
- (4r)-3-[[(2s)-5-oxo-2-pyrrolidinyl]carbonyl]-4-thiazolidinecarboxylic acid
- Pidotimod W S
- (4R)-3-[oxo-[(2S)-5-oxo-2-pyrrolidinyl]methyl]-4-thiazolidinecarboxylic acid
- Pidomomod
- Pidotimod Pidotimod
- Pidotimod>
- Pidolimod
- (R)-3-((S)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylicaci
- top quality Pidotimod
- (R)-3-[[(S)-5-Oxo-2-pyrrolidinyl]carbonyl]-1,3-thiazolidine-4-carboxylic Acid
- Pidotimod USP/EP/BP
- Pidotomod
- Pidotimod impurities1191
- PidotimodQ: What is
Pidotimod Q: What is the CAS Number of
Pidotimod Q: What is the storage condition of
Pidotimod Q: What are the applications of
Pidotimod
- -5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid
- Adimod
- 3-L-pyroglutaMyl-L-thiazolidine-4-carboxylic acid
- Pidomod
- Pidotimod IP Sec Std
- Pidotimod, ≥ 98.0%
- 121808-62-6
- 121808-92-6
- POLIMOD
- Chiral Reagents
- Intermediates & Fine Chemicals
- Pharmaceuticals
- Sulfur & Selenium Compounds
- API
- 121808-62-6
